- Home
- EXEL vs OWL Comparison
EXEL vs OWL Comparison
Compare EXEL & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- OWL
- Stock Information
- Founded
- EXEL 1994
- OWL 2020
- Country
- EXEL United States
- OWL United States
- Employees
- EXEL 1147
- OWL N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- OWL Investment Managers
- Sector
- EXEL Health Care
- OWL Finance
- Exchange
- EXEL Nasdaq
- OWL Nasdaq
- Market Cap
- EXEL 10.4B
- OWL 11.6B
- IPO Year
- EXEL 2000
- OWL N/A
- Fundamental
- Price
- EXEL $38.31
- OWL $19.05
- Analyst Decision
- EXEL Buy
- OWL Strong Buy
- Analyst Count
- EXEL 21
- OWL 14
- Target Price
- EXEL $43.65
- OWL $24.81
- AVG Volume (30 Days)
- EXEL 4.0M
- OWL 7.4M
- Earning Date
- EXEL 07-28-2025
- OWL 07-31-2025
- Dividend Yield
- EXEL N/A
- OWL 4.73%
- EPS Growth
- EXEL 81.76
- OWL 20.13
- EPS
- EXEL 2.08
- OWL 0.11
- Revenue
- EXEL $2,230,005,000.00
- OWL $2,618,831,000.00
- Revenue This Year
- EXEL $9.88
- OWL $18.76
- Revenue Next Year
- EXEL $12.59
- OWL $22.71
- P/E Ratio
- EXEL $18.45
- OWL $166.77
- Revenue Growth
- EXEL 10.73
- OWL 31.81
- 52 Week Low
- EXEL $25.12
- OWL $14.55
- 52 Week High
- EXEL $49.62
- OWL $26.73
- Technical
- Relative Strength Index (RSI)
- EXEL 41.08
- OWL 44.26
- Support Level
- EXEL $37.01
- OWL $18.74
- Resistance Level
- EXEL $38.78
- OWL $20.58
- Average True Range (ATR)
- EXEL 1.12
- OWL 0.71
- MACD
- EXEL 0.07
- OWL -0.04
- Stochastic Oscillator
- EXEL 83.79
- OWL 37.60
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.